Pleasanton, CA, United States of America

Peter Nellemann


Average Co-Inventor Count = 4.3

ph-index = 7

Forward Citations = 201(Granted Patents)


Company Filing History:


Years Active: 1996-2000

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Peter Nellemann in Nuclear Medicine

Introduction

Peter Nellemann is a notable inventor based in Pleasanton, California. He has made significant contributions to the field of nuclear medicine, holding a total of seven patents. His work focuses on improving imaging systems, which are crucial for accurate medical diagnostics.

Latest Patents

Among his latest patents is the "Dual-purpose radiation transmission source for nuclear medicine imaging." This invention describes a dual-purpose transmission source that utilizes a Cs-137 point source to transmit radiation during a transmission scan of an object. This technology is designed to enhance the accuracy of nuclear medicine imaging systems by correcting data for non-uniform attenuation. Another significant patent is the "Deadtime correction in a nuclear medicine imaging system." This method addresses the issue of deadtime in attenuation maps generated by imaging systems, ensuring more reliable results during scans.

Career Highlights

Peter Nellemann has dedicated his career to advancing nuclear medicine technology. His work at Adac Laboratories, Inc. has positioned him as a key figure in the development of innovative imaging solutions. His patents reflect a deep understanding of the complexities involved in nuclear medicine and a commitment to improving patient outcomes.

Collaborations

Peter has collaborated with notable colleagues such as Hugo Bertelsen and Horace H Hines. Their combined expertise has contributed to the successful development of advanced technologies in the field.

Conclusion

Peter Nellemann's contributions to nuclear medicine through his innovative patents demonstrate his commitment to enhancing medical imaging technologies. His work continues to impact the field positively, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…